Literature DB >> 9036367

[Value of cyclosporine in the treatment of the recurrence of nephrosis after renal transplantation].

B Ranchin1, M F Gagnadoux, M Broyer, A Lehnert, A Juresco, N Chérif, D Jan, D Droz, M C Gubler, P Niaudet.   

Abstract

From May 1992 to December 1994, 14 children with end stage renal failure secondary to steroid-resistant idiopathic nephrotic syndrome received a cadaver kidney graft. Immediate recurrence of the nephrotic syndrome occurred in four patients. In the four patients, a complete remission was observed shortly after the start of intravenous cyclosporin; two children received in addition methylprednisolone pulses for secondary rejection. Two children were still protein-free 9 and 15 months after transplantation. In the third patient, proteinuria relapsed after 9 months of complete remission and persisted in spite of the reintroduction of intravenous cyclosporin. The fourth graft was lost at 3.5 month from irreversible rejection. The creatinine clearance of the 3 functioning grafts was respectively: 73, 76 and 92 ml/mn/1.73 m2 16, 10 and 15 months after transplantation. Intravenous cyclosporin started shortly after the recurrence, maintaining blood levels between 200 and 300 ng/ml, may induce a remission in recurrent nephrotic syndrome after renal transplantation in childhood.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9036367

Source DB:  PubMed          Journal:  Nephrologie        ISSN: 0250-4960


  1 in total

1.  Complete remission of post-transplant FSGS recurrence by long-term plasmapheresis.

Authors:  Karsten Häffner; Lothar B Zimmerhackl; Christian von Schnakenburg; Matthias Brandis; Martin Pohl
Journal:  Pediatr Nephrol       Date:  2005-05-12       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.